News about KarXT

[everhopeful]

Ulotaront Effective for Negative Symptoms in Patients With Acute Schizophrenia

https://www.psychiatryadvisor.com/home/conference-highlights/psych-congress-2021/trace-amine-associated-receptor-1-agonist-ulotaront-for-negative-symptoms-in-schizophrenia/ Ulotaront was found to be effective at treating negative symptoms of schizophrenia, according to the results of an initial double-blind study presented at Psych Congress 2021, held from October 29 to November 1, in San Antonio, Texas. Ulotaront (previously SEP 363856) is an orally active psychotropic agent, being developed by Sunovion Pharmaceuticals